Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Valeo Pharma Inc
VPHIF
Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,...
Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:VPHIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(11)
•••
CamWisdom
X
View Profile
View Bullboard History
Post by
CamWisdom
on Feb 28, 2021 6:56pm
Big buys
Investors like what they see. Revs going to double this year at a minimum. - Cam
(103)
•••
ThisIsYerChance
X
View Profile
View Bullboard History
Comment by
ThisIsYerChance
on Feb 26, 2021 8:53pm
RE:RE:RE:RE:RE:RE:Sleeping Giant !!!
You got it all backwerdz.
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Feb 26, 2021 3:50pm
RE:RE:RE:RE:NEWS
AGREED! $4 to $5 by November. You will see the SP accelerate upwards once they report their Q2-2021 financials, end of April. From there the SP will just continue on its upward trend as
...more
(32)
•••
P_Money
X
View Profile
View Bullboard History
Post by
P_Money
on Feb 25, 2021 4:29pm
$0.99
WHAT A DEAL. Buying.
(24)
•••
lithuania
X
View Profile
View Bullboard History
Comment by
lithuania
on Feb 25, 2021 3:39pm
RE:RE:RE:RE:RE:Sleeping Giant !!!
Looks like fireworks to the downside this junk
(24)
•••
lithuania
X
View Profile
View Bullboard History
Comment by
lithuania
on Feb 25, 2021 3:39pm
RE:RE:Question for longs
Tank8ng badly every day for weeks now complete junk
(24)
•••
lithuania
X
View Profile
View Bullboard History
Comment by
lithuania
on Feb 25, 2021 3:37pm
RE:RE:RE:RE:NEWS
Tanking badly for weeks. What is the market not liking?
(24)
•••
lithuania
X
View Profile
View Bullboard History
Comment by
lithuania
on Feb 25, 2021 3:37pm
RE:Conference call set-up is promising, imo!
Wht tanking non stop for weeks now?
(56)
•••
LaurinDE
X
View Profile
View Bullboard History
Post by
LaurinDE
on Feb 19, 2021 9:16am
Conference call set-up is promising, imo!
Numbers and update on a Wednesday evening... Conference call on a Thursday morning... Live audio webcast of the conference call... You don't do that if you don't have anything good to say, imo
...more
(9)
•••
FluidDrummer
X
View Profile
View Bullboard History
Comment by
FluidDrummer
on Feb 19, 2021 8:33am
RE:RE:RE:NEWS
it's a $5 stock by November
(13)
•••
Indajungle1
X
View Profile
View Bullboard History
Comment by
Indajungle1
on Feb 18, 2021 11:45pm
RE:RE:NEWS
Yes they are in negociation with a business partner for distribution in the u.s
(56)
•••
LaurinDE
X
View Profile
View Bullboard History
Comment by
LaurinDE
on Feb 17, 2021 11:25am
RE:NEWS
I understand they sell Hesperco in Canada... do they also have the distribution rights for the US? L
(11)
•••
CamWisdom
X
View Profile
View Bullboard History
Post by
CamWisdom
on Feb 17, 2021 9:00am
NEWS
https://www.newswire.ca/news-releases/valeo-pharma-s-hesperco-tm-capsules-at-the-core-of-montreal-heart-institute-s-hesperidin-coronavirus-clinical-trial-881777084.html And this is just one of many
...more
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Feb 16, 2021 1:02am
RE:Question for longs
Huh? its called COVID delays for HC drug approvals. Oct 31st 2020 YE report coming out last week of February 2021. Check it out. CFO has stated they will be EBDITA +ve for the YE
...more
(94)
•••
Troy23
X
View Profile
View Bullboard History
Post by
Troy23
on Feb 13, 2021 1:41pm
Question for longs
I like the potential here but considering the latest financial report ended July 31st where they reported 1.49 million in revs...cost of goods was 1,36 million, how can you have a decent bottom line
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company